Diagnostic efficacy of three test kits for SARS-CoV-2 nucleic acid detection
Detection Principle
NucleicAcid-PCR based
Target
Not specified (article in Chinese)
Testing Method Category
PCR_KIT
Testing Method
Kits
Testing Method - Additional Info
Sansure Biotech, Jiangsu Bioperfectus Technologies and BGI Genomics
Reported Performance
sensitivity: 95% (Sansure), 90% (Bioperfectus), 82.50% (BGI); specificity: 87.50% (Sansure), 87.50% (Bioperfectus), 81.25% (BGI); PPV: 95.00% (Sansure), 94.74 (Bioperfectus), 91.67% (BGI); NPV: 87.50% (Sansure), 77.78% (Bioperfectus), 65% (BGI); kappa value: 0.825 (Sansure), 0.747 (Bioperfectus), 0.593 (BGI)
Sample Size
40 cases & 16 controls
Peer-reviewed
yes (paper not in English)
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements